Nutriband Inc. has successfully completed the scale-up of the commercial manufacturing process for its lead product, Aversa™ Fentanyl, in partnership with Kindeva, a contract development and ...

Completing the commercial manufacturing scale-up is an important step towards development of a commercially viable product and eventual NDA filing. This achievement demonstrates the compatibility of ...

"US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: Download Report: https://www.kuickresearch.com/report-us-transdermal ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global transdermal skin patches market is projected to grow from USD 9.4 billion in 2025 to USD 15.6 billion by 2035, representing a compound annual growth ...

Nutriband and Kindeva have completed commercial manufacturing process scale-up for its lead product Aversa™ Fentanyl, an abuse-deterrent fentanyl patch Nutriband is partnering with Kindeva to develop ...